💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Acceleron Pharma Inc. (XLRN)
« Back to company indexXLRN Chatter Timeline
Stock Ticker for XLRN
Most Active Tweeters for XLRN
| User | Tweets |
|---|---|
| @BigCForever | 1 |
| @z7rw85jjgd | 1 |
| @Biohazard3737 | 1 |
| @PaulTorresCohen | 1 |
Recent Tweets for XLRN
 |
@Biohazard3737 What about Hep C? Sure, Pharmasset got bought for $11Bn. But so did $XLRN last year and nobody perceived that to be… https://t.co/qTj0q1DQqW January 24th 2022, 2:01am |
 |
@z7rw85jjgd @adar170 Also some option volume - though anemic. The green candle at close reminds me of $xlrn before leak… January 20th 2022, 3:01am |
 |
@BigCForever @stevedoc22 @bradloncar $xlrn went 11.5B By no means discounted premium. January 19th 2022, 7:01pm |
 |
@PaulTorresCohen Paul Torres-Cohen $XLRN January 13th 2022, 5:01am |
 |
@bigpharmaguy @adamfeuerstein Not at all. Companies like $XLRN getting acquired for 10b+ with double digit royalties owed. 4% doesn’t tarnish the asset January 7th 2022, 3:01pm |
 |
@trackfunds 67 more funds holding $XLRN vs last quarter!! #xlrn #stocks #investing #finance #stockmarket #stock #trading Find o… https://t.co/21yP8MNlyI December 18th 2021, 12:12am |
|
@trackfunds 14 funds holding $XLRN as one of their top ten holdings. This is up 3 vs last quarter!!#xlrn #stocks #investing… https://t.co/1vMYmOIKVD December 14th 2021, 12:12am |
 |
@adar170 @bradloncar of the few funds having very solid year $XLRN $ARNA December 13th 2021, 6:12pm |
|
@trackfunds 67 More Funds Holding Positions in $XLRN vs Last Quarter!!#xlrn #stocks #investing #finance Find out more: https://t.co/mzNQioP8S8 December 13th 2021, 1:12am |
 |
@ChartMill $XLRN was analyzed by 17 analysts. The buy consensus is at 73%. So analysts seem to be mildly confident about $ ...… https://t.co/0jMjQgDTn7 December 11th 2021, 8:12pm |
|
@ChartMill $XLRN was analyzed by 17 analysts. The buy consensus is at 73%. So analysts seem to be mildly confident about $ ...… https://t.co/mFj29NiNwX December 8th 2021, 11:12pm |
 |
@Tickeron $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on November 17, 2021. View odds for… https://t.co/XuUm7TdyUs December 8th 2021, 5:12am |
 |
@PantaRhai The 10-20bn mid cap biotech group is pretty deserted post $XLRN. Few options around. That means high quality mid ca… https://t.co/dl7reG6iqy December 3rd 2021, 7:12pm |
|
@adar170 wonder if those funds that wanted to block $MRK $XLRN from closing now happy? December 3rd 2021, 5:12pm |
 |
@investor_feed $XLRN 15-12B Acceleron Pharma (2 Dec, 9:00am) ? Securities registration termination https://t.co/OiDpfw4tJy… https://t.co/HpIDxgPy4k December 2nd 2021, 2:12pm |
 |
@OptionHunt Ticker $XLRN Unusual Volume Detected: 307.72% over average December 1st 2021, 5:12pm |
 |
@FlashAlert_me $XLRN [15s. delayed] filed form SC 13D/A on November 24, 15:48:08 https://t.co/SG5uzUiqlL November 24th 2021, 8:11pm |
 |
@whalewisdom New SC 13D/A from AVORO CAPITAL ADVISORS LLC concerning $XLRN. See details at https://t.co/3CKx2PmkLb November 24th 2021, 8:11pm |
 |
@newsfilterio Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC $XLRN https://t.co/IbZQAujElM November 24th 2021, 8:11pm |
 |
@quantisnow $XLRN ? SEC Form SC 13D/A filed by Acceleron Pharma Inc. (Amendment) https://t.co/i80NDCJOFN 45 seconds delayed. November 24th 2021, 8:11pm |
 |
@TickwatcherMF $XLRN company #profile, #Fundamental and #Technical Analysis Score Update (FA Score, TA Score) #stocks #stock… https://t.co/2FEePXCJp2 November 24th 2021, 7:11pm |
|
@Tickeron $XLRN in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 17, 2021. View od… https://t.co/xU4EibI2OE November 23rd 2021, 7:11pm |
 |
@shortablestocks Zero shares available to short currently in $XLRN. https://t.co/HzmrmIa4Gw https://t.co/d6ih50avOh November 23rd 2021, 7:11pm |
 |
@Livetradeview1 $XLRN Real price will come out soon; Follow price targets. https://t.co/0bnRJkAVfJ November 23rd 2021, 5:11pm |
 |
@AlertTrade RT @AlertTrade: TRADING HALT: $XLRN via ? https://t.co/BCEHq7Ce2N November 23rd 2021, 1:11pm |
 |
@Biotech2050 @MaxJacobsEdison Except $XLRN holders. November 23rd 2021, 1:11pm |
 |
@trendwhizo $XLRN long stock with covered calls at 180 (Feb and beyond expiry) worked quite well. #mergerarb #alpha… https://t.co/CMYfVk5YOf November 23rd 2021, 11:11am |
 |
@MarcJacksonLA $MRK $XLRN Merck Closes Biggest Biotech Deal of the Year https://t.co/8EdSGXCaQq via @Barronsonline November 22nd 2021, 3:11pm |
|
@trendwhizo @sharkbiotech Funds fighting for higher bid on $XLRN could be even: 1. desperate attempt to boost returns in a y… https://t.co/0AMfCiaogt November 22nd 2021, 2:11pm |
|
@investor_feed $XLRN 8-K Acceleron Pharma (22 Nov, 8:52am) ? Completion of Acquisition or Disposition of Assets; Notice of De… https://t.co/OtSYsfYHJ9 November 22nd 2021, 1:11pm |
|
@Tickeron $XLRN in Downtrend: its price may drop because broke its higher Bollinger Band on November 17, 2021. View odds for… https://t.co/JYhvOJ1JQq November 22nd 2021, 1:11pm |
|
@quantisnow $XLRN ? SEC Form SC 14D9/A filed by Acceleron Pharma Inc. (Amendment) https://t.co/xhRC7UZrjD 45 seconds delayed. November 22nd 2021, 12:11pm |
|
@FlashAlert_me $XLRN [15s. delayed] filed form SC 14D9/A on November 22, 07:02:02 https://t.co/Q7B8j8Nt7L November 22nd 2021, 12:11pm |
|
@quantisnow $XLRN ? SEC Form SC TO-T/A filed by Acceleron Pharma Inc. (Amendment) https://t.co/QA8LqNU70q 45 seconds delayed. November 22nd 2021, 12:11pm |
|
@FlashAlert_me $XLRN [15s. delayed] filed form SC TO-T/A on November 22, 07:01:29 https://t.co/owNwEy7IrE November 22nd 2021, 12:11pm |
 |
@LargeVoidBot $XLRN Halt - Additional Information Requested by NASDAQ. Halt time: 11/19/2021 19:50:00. November 22nd 2021, 12:11pm |
 |
@63_hyacinth Merck completes acquisition of Acceleron $MRK $XLRN November 22nd 2021, 11:11am |
|
@FlashAlert_me $XLRN [15s. delayed]: Issued Press Release on November 22, 06:45:00: Merck Completes Acquisition of Acceleron Pharm… https://t.co/9uvEwC2hG8 November 22nd 2021, 11:11am |
|
@newsfilterio Merck Completes Acquisition of Acceleron Pharma $MRK $XLRN https://t.co/7f7LeS13gp November 22nd 2021, 11:11am |
 |
@StockNewsBot2 $MRK $XLRN Merck Completes Acquisition of Acceleron Pharma Inc. https://t.co/Oajzf5kU21 November 22nd 2021, 11:11am |
|
@quantisnow $XLRN $MRK ? Merck Completes Acquisition of Acceleron Pharma Inc. https://t.co/RNOiQZNIiY 45 seconds delayed. November 22nd 2021, 11:11am |
 |
@stock_titan $MRK $XLRN Merck Completes Acquisition of Acceleron Pharma Inc. https://t.co/DRwLuvh41P November 22nd 2021, 11:11am |
 |
@InsiderForms $XLRN Trading Halted for Acceleron Pharma Inc. Cmn (XLRN). Halt Reason: ADDITIONAL INFORMATION REQUESTED BY NASDAQ.… https://t.co/FnJVZFVL1i November 22nd 2021, 11:11am |
 |
@realmaciej RT @sharkbiotech: the hedge fund fight to coax a better bid from $MRK for $XLRN was a pointless waste of press releases November 21st 2021, 5:11pm |
 |
@sharkbiotech the hedge fund fight to coax a better bid from $MRK for $XLRN was a pointless waste of press releases November 21st 2021, 4:11pm |
 |
@mehabecapital $XLRN @ 178.75 (-0.52%) : Merck completes tender offer for $11B Acceleron Pharma acquisition https://t.co/ZSlovokRMs November 21st 2021, 12:11am |
 |
@cmb_ab RT @MarcJacksonLA: $XLRN $MRK Merck Completes Tender Offer to Acquire Acceleron Pharma Inc. | Business Wire https://t.co/7ddYTdyfpc November 20th 2021, 10:11pm |
|
@MarcJacksonLA $XLRN $MRK Merck Completes Tender Offer to Acquire Acceleron Pharma Inc. | Business Wire https://t.co/7ddYTdyfpc November 20th 2021, 6:11pm |
|
@mehabecapital $XLRN @ 178.75 (-0.52%) : Merck completes tender offer for $11B Acceleron Pharma acquisition https://t.co/9fMxAijUCo November 20th 2021, 4:11pm |
 |
@LiquidityNews NYSE Chicago Top 3 most-shorted Stocks (based on Share Volume not Dollar Value): $RBLX 56,319 shares | $XLRN 40,4… https://t.co/XmvlkZ0a1X November 20th 2021, 5:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?